Extended Evaluation of Deferasirox Film-coated Tablet (FCT) Formulation
NCT02720536
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
53
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Iron Overload
Interventions
DRUG:
Deferasirox
Sponsor
Novartis Pharmaceuticals